(-0.41%) 5 460.48 points
(-0.12%) 39 119 points
(-0.71%) 17 733 points
(-0.34%) $81.46
(-3.13%) $2.60
(0.01%) $2 336.90
(0.61%) $29.44
(0.28%) $1 009.00
(-0.06%) $0.933
(0.45%) $10.68
(-0.05%) $0.791
(0.86%) $85.73
Live Chart Being Loaded With Signals
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally...
Stats | |
---|---|
Šios dienos apimtis | 7.95M |
Vidutinė apimtis | 749 104 |
Rinkos kapitalizacija | 672.28M |
EPS | $-0.0369 ( Q1 | 2023-09-30 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-5.86 (Sector) 49.64 (Industry) 37.79 |
ATR14 | $0.0480 (0.49%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-20 | Williamson Robert F Iii | Buy | 23 000 | Stock option (right to buy) |
2024-06-20 | Morich Frank | Buy | 23 000 | Stock option (right to buy) |
2024-06-20 | Woods Lori A | Buy | 23 000 | Stock option (right to buy) |
2024-06-20 | Henson Heidi | Buy | 23 000 | Stock option (right to buy) |
2024-06-20 | Spoor Johan M. | Buy | 500 000 | Stock option (right to buy) |
INSIDER POWER |
---|
99.90 |
Last 36 transactions |
Buy: 62 148 790 | Sell: 30 000 |
Tūris Koreliacija
Perspective Therapeutics, Koreliacija
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
AIU | -0.865 |
CCG | -0.832 |
BBAI-WT | -0.828 |
QBTS | -0.82 |
GETR | -0.807 |
RTO | -0.806 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Perspective Therapeutics, Koreliacija - Valiuta/Žaliavos
Perspective Therapeutics, Finansinės ataskaitos
Annual | 2022 |
Pajamos: | $7.10M |
Bruto pelnas: | $1.63M (23.00 %) |
EPS: | $-0.100 |
FY | 2022 |
Pajamos: | $7.10M |
Bruto pelnas: | $1.63M (23.00 %) |
EPS: | $-0.100 |
FY | 2022 |
Pajamos: | $10.80M |
Bruto pelnas: | $4.62M (42.76 %) |
EPS: | $-0.0504 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Perspective Therapeutics,
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.